Toxicological Studies
Toxicological Division
Delivering Trusted Science for a Safer Tomorrow
With over four decades of experience in toxicity studies for establishing the safety and efficacy of agrochemical compounds, novel molecules, drugs, pharmaceutical products, and medical devices, Shriram Institute for Industrial Research (SRI), Delhi has been serving industry in compliance with national and international guidelines such as OECD, OPPTS, ISO 10993, and New Drugs and Clinical Trials Rules, 2019 (NDCTR).
SRI Delhi is a not-for-profit, multidisciplinary Contract Research and Testing Organization (CRTO) offering comprehensive technical expertise, GLP-compliant testing, and regulatory consultancy services to agrochemical, pharmaceutical, medical device, feed, and food manufacturers.
Our Expertise
In today’s complex regulatory environment, our primary objective is to support clients at every stage of the product registration process. We specialize in both in vivo (animal) and in vitro (cell line-based) studies to evaluate safety and efficacy.
Our integrated regulatory services are managed by an experienced in-house team, ensuring seamless submission of reports. Our scientific team brings over 100 years of combined experience, supported by state-of-the-art instrumentation compliant with 21 CFR Part 11 and GLP standards.
Recent Advancement
We have established a specialized Inhalation Toxicology Facility to conduct studies on fumigants and novel gaseous compounds for acute and sub-acute toxicity studies as per national and international guidelines.
Toxicology Services Offered
- Six-pack acute toxicity studies on agrochemicals
- Biocompatibility testing on medical devices (ISO 10993)
- Safety assessment studies of drug molecules (NDCTR 2019)
- Long-term, sub-chronic, chronic, and carcinogenicity studies
- Mutagenicity / Genotoxicity studies
- Reproductive toxicity studies